Article

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression

2020-04-02

Abstract excerpt

<h4>Background</h4> Predictors of treatment outcome in major depressive disorder (MDD) could contribute to evidence-based therapeutic choices. This study tested the cost-effectiveness of a pharmacogenetic and clinical predictive model (PGx-CL-R) vs a clinical risk (CL-R) predictive model in guiding the assignment of combined pharmacotherapy and psychotherapy vs pharmacotherapy in MDD. <h4>Methods</h4> We hypothesi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 248807fc-0b52-560d-8932-f2347f9bf00a
DOI: 10.1101/2020.03.31.20048538

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depressionDOI 10.1101/2020.03.31.20048538Read

Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.Semantic proximity Read

Genotype-Guided Antidepressant Prescribing for Patients With Depression: A Randomized Clinical Trial.Semantic proximity Read

Decoding Treatment Choice: Genetic and Phenotypic Analyses of Long-term Antidepressant AcceptabilitySemantic proximity Read

Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.Semantic proximity Read

Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohortsSemantic proximity Read

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.Semantic proximity Read

Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.Semantic proximity Read

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotypingSemantic proximity Read

Optimizing Treatment for Depression in Primary Care Using Psychotherapy Versus Antidepressant Medication in a Low-Resource Setting: Protocol for the OptimizeD Randomized Controlled TrialSemantic proximity Read

Developing a multivariable prediction model to support personalized selection among five major empirically-supported treatments for adult depression. Study protocol of a systematic review and individual participant data network meta-analysis.Semantic proximity Read

Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive DisorderSemantic proximity Read

Genome-wide association study of treatment resistant depression highlights shared biology with metabolic traitsSemantic proximity Read